Opening book details…
Can I read Potential Medicare and Medicaid Savings on Anti-CD20 Therapy for Multiple Sclerosis on EtoBox?
Potential Medicare and Medicaid Savings on Anti-CD20 Therapy for Multiple Sclerosis by John Kim; Aaron S. Kesselheim; Riley Bove; Jerry Avorn; Benjamin N. Rome is a Medicine article available to read on EtoBox.
What is Potential Medicare and Medicaid Savings on Anti-CD20 Therapy for Multiple Sclerosis about?
This cross-sectional study compares price data for ocrelizumab and rituximab to estimate the savings to Medicare and Medicaid if rituximab were used in the treatment of multiple sclerosis instead of the higher-priced ocrelizumab.
Who reads Potential Medicare and Medicaid Savings on Anti-CD20 Therapy for Multiple Sclerosis?
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- John Kim; Aaron S. Kesselheim; Riley Bove; Jerry Avorn; Benjamin N. Rome
- Publisher
- American Medical Association (AMA)
- Published
- 2024
- Language
- EN
- Field
- Medicine (Health Sciences)
More by John Kim; Aaron S. Kesselheim; Riley Bove; Jerry Avorn; Benjamin N. Rome
Browse all works by John Kim; Aaron S. Kesselheim; Riley Bove; Jerry Avorn; Benjamin N. Rome